ResMed Inc (RMD)
Operating return on assets (Operating ROA)
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 1,612,039 | 1,560,355 | 1,418,207 | 1,319,892 | 1,213,942 | 1,140,029 | 1,145,129 | 1,131,871 | 1,112,000 | 1,045,594 | 1,014,111 | 1,000,285 | 986,526 | 975,687 | 948,692 | 903,675 | 885,285 | 879,359 | 855,452 | 809,658 |
| Total assets | US$ in thousands | 7,566,820 | 7,141,330 | 7,222,420 | 6,872,390 | 6,814,560 | 6,905,090 | 6,740,790 | 6,751,710 | 6,713,880 | 6,676,100 | 5,177,560 | 5,095,850 | 4,905,260 | 4,734,740 | 4,729,170 | 4,728,120 | 4,585,720 | 4,572,860 | 4,620,840 | 4,587,380 |
| Operating ROA | 21.30% | 21.85% | 19.64% | 19.21% | 17.81% | 16.51% | 16.99% | 16.76% | 16.56% | 15.66% | 19.59% | 19.63% | 20.11% | 20.61% | 20.06% | 19.11% | 19.31% | 19.23% | 18.51% | 17.65% |
March 31, 2025 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $1,612,039K ÷ $7,566,820K
= 21.30%
The operating return on assets (ROA) of ResMed Inc. has exhibited variability over the period from June 2020 through March 2025. Starting at 17.65% as of June 30, 2020, the metric demonstrated a generally upward trend, reaching a peak of 21.85% on December 31, 2024. This indicates that the company's efficiency in generating operating income from its assets improved over this period. Notably, the ROA increased notably from 16.56% at the end of March 2023 to 21.85% by the end of 2024, reflecting a significant enhancement in operational efficiency or asset utilization during this span.
In the period prior to this peak, the ROA experienced some fluctuations, with a decline observed between December 2022 (15.66%) and March 2023 (16.56%), followed by a steady increase reaching throughout 2024. The data suggests that during 2024, ResMed significantly increased its operating efficiency relative to its asset base. The latest figure available as of March 2025 stands at 21.30%, slightly lower than the peak at the end of 2024 but still indicative of strong operational performance.
Overall, the trend reflects a positive trajectory in ResMed’s operational efficiency over the specified period, with periods of fluctuation but an overall improvement, culminating in one of the highest operating ROA figures observed in the provided data. This progression suggests effective asset management and operational strategies that have contributed to enhanced profitability relative to the assets employed.
Peer comparison
Mar 31, 2025